JVL Associates’s Zomedica Corp. ZOM Stock Holding History

JVL Associates’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-58,500	Closed	-$13K	–	38
2020 Q4	$13K	Hold	58,500	–	–	0.01%	37
2020 Q3	$6K	Hold	58,500	–	–	0.01%	39
2020 Q2	$14K	Hold	58,500	–	–	0.01%	38
2020 Q1	$11K	Hold	58,500	–	–	0.01%	41
2019 Q4	$19K	Hold	58,500	–	–	0.02%	40
2019 Q3	$22K	Hold	58,500	–	–	0.02%	41
2019 Q2	$13K	Hold	58,500	–	–	0.01%	41
2019 Q1	$20K	Hold	58,500	–	–	0.02%	41
2018 Q4	$72K	Hold	58,500	–	–	0.08%	36
2018 Q3	$109K	Hold	58,500	–	–	0.1%	38
2018 Q2	$132K	Hold	58,500	–	–	0.13%	37
2018 Q1	$129K	Hold	58,500	–	–	0.13%	35
2017 Q4	$116K	Buy	+58,500	New	+$130K	0.12%	37

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JVL Associates's ZOM Position: Q1 2021 in Review

JVL Associates sold out of Zomedica Corp. (ZOM) in Q1 2021, closing a stake of 58,500 shares — an estimated $13K sold.

JVL Associates first reported a position in ZOM in Q4 2017 and held it in 13 quarters. The position peaked at $132K in Q2 2018. 102 funds tracked by Wall St. Rank hold ZOM as of Q1 2021.

JVL Associates reported no remaining Zomedica Corp. position as of Q1 2021 after selling out during the quarter.
JVL Associates sold 58,500 Zomedica Corp. shares in Q1 2021, an estimated $13K.
JVL Associates first reported a position in Zomedica Corp. in Q4 2017 and held it in 13 quarters.
JVL Associates's Zomedica Corp. position peaked at $132K in Q2 2018.
102 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2021.

Based on JVL Associates's 13F filing for Q1 2021, filed 8 Mar 2022.